Covered recipient · General Payments record
ROMAN ERIC POLITI
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2019–2025
$200,828.11
- Reported across 909 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $7,875.00 | 3 |
| Food and Beverage | $2,063.69 | 55 |
| Education | $76.99 | 1 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $8,185.37 | 11 |
| TG THERAPEUTICS, INC. | $353.46 | 6 |
| EMD Serono, Inc. | $284.77 | 3 |
| Alexion Pharmaceuticals, Inc. | $257.17 | 3 |
| Lundbeck LLC | $145.53 | 2 |
| UCB, Inc. | $137.32 | 3 |
| Janssen Biotech, Inc. | $129.40 | 3 |
| Neurelis, Inc. | $55.94 | 3 |
| EISAI INC. | $52.04 | 3 |
| Biogen, Inc. | $45.74 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $43.16 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $40.91 | 2 |
| Neurocrine BioSciences, Inc. | $36.75 | 2 |
| ARGENX US, INC. | $35.12 | 2 |
| Lilly USA, LLC | $33.50 | 2 |
| ACADIA Pharmaceuticals Inc | $32.33 | 2 |
| Novo Nordisk AS | $29.38 | 2 |
| LivaNova USA, Inc. | $28.81 | 1 |
| Merz Pharmaceuticals, LLC | $20.05 | 1 |
| Amneal Pharmaceuticals LLC | $19.30 | 1 |
| SK Life Science, Inc. | $18.84 | 1 |
| Teva Pharmaceuticals USA, Inc. | $16.83 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $13.96 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (59)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.